Literature DB >> 15570630

Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease.

Michelle A Petri.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15570630

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

1.  Antiphospholipid Syndrome: A complex disease.

Authors:  Fátima Serrano
Journal:  J Nephropathol       Date:  2013-01-01

2.  Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.

Authors:  I Krause; S Lev; A Fraser; M Blank; M Lorber; L Stojanovich; J Rovensky; J Chapman; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

Review 3.  Valvular heart disease in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Olivier Huttin; Shirine Mohamed; Pierre-Yves Marie; Christine Selton-Suty; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

Review 4.  The Heart and APS.

Authors:  Mary-Carmen Amigo
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

5.  Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

Authors:  Natee Sirinvaravong; Mary C Rodriguez Ziccardi; Soumya Patnaik; Mahek Shah; Gustavo Fernandez; Jose-Nitram Aliling; Alexander Rubin
Journal:  Oxf Med Case Reports       Date:  2018-06-25

Review 6.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

7.  Immunomodulation in antiphospholipid-antibody-associated endocarditis: a case report and review of the literature.

Authors:  Franz Haertel; Daniel Kretzschmar; P Christian Schulze; Thomas Neumann
Journal:  Eur Heart J Case Rep       Date:  2021-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.